Suri Biotech
Z├╝rich · Founded 2020
About Suri Biotech
Suri Biotech is a biotechnology company, developing health-promoting bacterial strains with targeted mechanisms of action for the alleviation of bloating and intestinal discomfort. The company's proprietary strains reduce the production of hydrogen gas by intestinal microorganisms – with potential applications in multiple functional gastrointestinal disorders (e.g. infant colic, lactose intolerance, bloating).
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $156.1K
- Last round: Non-Equity Assistance (Jun 2023)
- Website: http://suribiotech.com
- Phone: +41 78 618 53 12
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/suri-biotech-176546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.